Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CLOV
BUYClover Health Investments, Corp. · Healthcare · United States · $2.3B · Avg Vol: $29M/d
COMPANY DESCRIPTION
Clover Health Investments, Corp. is a Medicare Advantage insurer that leverages its proprietary AI-powered technology platform, Clover Assistant, to proactively manage and improve health outcomes for its members. The company aims to differentiate itself by using data analytics to identify and address health risks, positioning itself as a technology-driven disruptor in the traditional healthcare plans market.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.1B | 1.3B | 1.4B | 1.9B | 20.6% | 2.2B | 2.9B | 3.4B | 33.0% |
| EPS | — | -0.71 | -0.44 | -0.08 | -0.17 | — | -0.12 | — | — | — |
| Shares | — | 478.4M | 489.1M | 503.5M | 519.0M | +8.5% | 431.0M | — | — | — |
| Debt | 27.8M | 5.9M | 4.7M | — | — | -59.1% | — | — | — | — |
| Equity | — | 356.9M | 286.4M | 341.1M | 308.7M | -4.7% | — | — | — | — |
| Op CF | — | -203.9M | -144.7M | 34.8M | -66.9M | — | 57.3M | — | — | — |
| Inv CF | — | 95.1M | 140.0M | 0.6M | 4.1M | — | — | — | — | — |
| Fin CF | — | -5.0M | -5.1M | -17.4M | -53.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CLOV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CLOV | Clover Health Investments, Corp.(you) | $2.3B | 73 | BUY |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| ALHC | Alignment Healthcare, Inc. | $4.0B | 53 | HOLD |
| MOH | Molina Healthcare, Inc. | $10.3B | 77 | BUY |
| OSCR | Oscar Health, Inc. | $8.5B | 88 | STRONG BUY |
| HUM.MX | Humana Inc. | $24.1B | 83 | STRONG BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| CI | The Cigna Group | $76.6B | 97 | STRONG BUY |
| CVS | CVS Health Corporation | $137.5B | 90 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.7%